Ignite Creation Date:
2024-05-05 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00439192
Status:
TERMINATED
Last Update Posted:
2007-08-08
First Post:
2007-02-22
Brief Title:
ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder OAB
Sponsor:
elbion AG
Organization:
elbion AG
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-02
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2007-08
Completion Date Type:
ACTUAL
First Submit Date:
2007-02-22
First Submit QC Date:
February 22 2007
Study First Post Date:
2007-02-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2007-08-07
Last Update Post Date:
2007-08-08
Last Update Post Date Type:
ESTIMATED